Merlin Biotech, which operates out of the Pennsylvania Biotechnology Center of Bucks County, intends to initially focus on chronic hepatitis B infections, adult and pediatric cancers, and Lyme disease.
Read the full article at: www.bizjournals.com
Blumberg Institute Spins Out Biotech Firm to Develop mRNA Therapies and Vaccines
